Cellular and tissue context is paramount; the downstream consequences of miR-21 targeting specific genes (like PTEN or PDCD4) may differ significantly depending on the specific GI cell type, the cancer stage, and the surrounding tumor microenvironment (TME). The gene discussed is PDCD4; the disease is neoplasm.